Emetrol Chewables Orange Tablet, Chewable
Product Images NDC 65197-410

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Emetrol Chewables Orange (NDC 65197-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wellspring Pharmaceutical Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ifc Emetrol Chewable Tablet Orange (Emetrol Chewables Orange 1)

Ifc Emetrol Chewable Tablet Orange (Emetrol Chewables Orange 1)
Emetrol Chewables Orange 230 mg chewable tablets by WellSpring Pharmaceutical Corporation. The label highlights rapid nausea relief with non-drowsy, great-tasting orange flavored tablets formulated for adults. The packaging contains 60 chewable tablets and emphasizes treating the source of nausea with no acetaminophen, aspirin, or caffeine. Includes storage and ingredient information, directions, warnings, and a money-back guarantee statement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.